تداخل‌های دارویی
Interferon beta 1a + Tisagenlecleucel
شدت: شدید
Interferon beta 1a and Tisagenlecleucel: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Tisagenlecleucel is a CAR-T cell therapy that causes prolonged cytopenias and immune compromise. Interferon beta may add to immune and blood count effects and could influence CAR-T cell activity. Clinical data on the combination are lacking.
معنای این تداخل به زبان ساده
Interferon beta 1a and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Interferon beta 1a belongs to Central Nervous System; Tisagenlecleucel belongs to Oncology.
چرا رخ می‌دهد
Additive immunosuppressive and myelosuppressive effects; the effect on CAR-T expansion is not established.
اقدام لازم
Avoid interferon beta around CAR-T therapy and choose an alternative where possible. If coadministered, monitor blood counts and infection signs closely.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Interferon beta 1a و Tisagenlecleucel، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Interferon beta 1a
تداخلات دیگر Tisagenlecleucel
پرسش‌های متداول
Can I take Interferon beta 1a with Tisagenlecleucel?
MediHelp rates the interaction as major. Interferon beta 1a and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Tisagenlecleucel is a CAR-T cell therapy that causes prolonged cytopenias and immune compromise. Interferon beta may add to immune and blood count effects and could influence CAR-T cell activity. Clinical data on the combination are lacking.
How serious is the interaction between Interferon beta 1a and Tisagenlecleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid interferon beta around CAR-T therapy and choose an alternative where possible. If coadministered, monitor blood counts and infection signs closely.
What other medicines interact with Interferon beta 1a?
MediHelp also lists interactions of Interferon beta 1a with, for example, Deferiprone, Etrasimod, Hydroxyurea. The full list is on the Interferon beta 1a page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
